Benefit risk

Benefit Risk considerations

Benefit risk considerations

Benefit Risk considerations

RISK BENEFIT ANALYSIS

Benefit Risk considerations

Overall conclusion on benefit risk

Overall risk benefit assessment

Benefit risk assessment

Benefit Risk considerations

However, the total number of women exposed to loratadine in these studies is less than 200.

GROUNDS FOR AMENDMENT OF THE SUMMARY(IES) OF PRODUCT CHARACTERISTICS

5.1 Risk benefit sharing according to market conditions

Amendment 20 on benefit risk analysis

Overall conclusion on benefit risk

Physicians are advised to monitor the growth of children taking ribavirin in

Ideally, drugs should have a favorable risk benefit ratio.

In these women, the benefits of gonadotrophin administration need to be weighed against the risks.

In these women, the benefits of gonadotrophin administration need to be weighed against the risks.

What are the benefit and risk of Myfenax?

41 patient, which should take into account the specific clinical context.

52 patient, which should take into account the specific clinical context.

The decision to administer recombinant erythropoietins should be based on a benefit risk assessment with the participation of the individual patient, which should take into account the specific clinical context.

What are the benefit and risk of Zalasta?

For Lisonorm (new lisinopril 10mg amlodipine 5mg combination), a positive benefit risk ratio had not been established given that the initial bioequivalence study submitted was not conducted with the appropriate control, and that preliminary results of a new bioequivalence study (No.67289) did not allow a full assessment of the benefit risk ratio.

(a) the benefit risk balance of the veterinary medicinal product is unfavourable

(a) the benefit risk balance of the veterinary medicinal product is unfavourable

In these women, the benefits of gonadotrophin administration need to be weighed against the risks.

Utilisation during pregnancy requires that the potential benefit justifies the potential risk to the foetus.

What are the benefit and risk of Irbesartan Krka?

The potential risk to benefit ratio should be carefully evaluated before considering vaccination in such cases.

What are the benefit and risk of Mycophenolate mofetil Teva?

What are the benefit and risk of Olanzapine Neopharma?

What are the benefit and risk of Olanzapine Teva?

What are the benefit and risk of Pramipexole Teva?

Why has Ribavirin Teva been approved?

the Committee considered the risk benefit balance of chlormezanone.

Use only accordingly to the risk benefit assessment by the responsible veterinarian.

Please tell your doctor if you are pregnant.

On 21 April 2005 the European Commission in view of the potential risk of malignancies requested the Opinion of the CHMP on the benefit risk profile of Protopic.

is On 21 April 2005 the European Commission in view of the potential risk of malignancies requested the Opinion of the CHMP on the benefit risk profile of Protopy.

Bleeding risk should be taken into account when considering the risk benefit for individual patients.

14 Bleeding risk should be taken into account when considering the risk benefit for individual patients.

The Committee, as a consequence, considered the benefit risk balance of medicinal products

the CHMP considered the benefit risk of Rapinyl to be positive